Low-dose renin inhibitor and low-dose AT1-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes

by Ralf Dechend, Erdenechimeg Shagdarsuren, Petra Gratze, Anette Fiebeler, Bernhard Pilz, Silke Meiners, Wolfgang Derer, David L Feldman, Randy Webb, Dominik N Muller
Published 2007-06-01